An antifungal protein from Escherichia coli

Journal of Medical Microbiology

Volumn 56, Issue 5, 2007, Pages 637-644

  Yadav, V ^a   Mandhan, R ^b   Pasha, Q ^a   Pasha, S ^a   Katyal, A ^c   Chhillar, A K ^d   Gupta, J ^a   Dabur, R ^e   Sharma, G L ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b KURUKSHETRA UNIVERSITY   (India)

^c UNIVERSITY OF DELHI   (India)

^d SHRIRAM INSTITUTE FOR INDUSTRIAL RESEARCH   (India)

^e Regional Research Institute (Ay)   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL DEHYDROGENASE; AMINO ACID; AMPHOTERICIN B; ANTIFUNGAL AGENT; ASPARTYLLEUCYLALANYLGLUTAMYLVALYLALANYLSERYLARGININE; ESCHERICHIA COLI PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; BACTERIAL STRAIN; CANDIDA ALBICANS; CONTROLLED STUDY; DNA FINGERPRINTING; ERYTHROCYTE; ESCHERICHIA COLI; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PROTEIN PURIFICATION; TOXICITY TESTING;

ALCOHOL DEHYDROGENASE; AMINO ACID SEQUENCE; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLUS; CANDIDA ALBICANS; ERYTHROCYTES; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; HUMANS; MICROBIAL SENSITIVITY TESTS; SEQUENCE HOMOLOGY, AMINO ACID; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 34248148569     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.46973-0     Document Type: Article

References (39)

1. Antoine, E., Rolland, J.-H., Raffin, J.-P. & Dietrich, J. (1999). Cloning and over-expression in Escherichia coli of the gene encoding NADPH group III alcohol dehydrogenase from Thermococcus hydrothermalis. Eur J Biochem 264, 880-889.
2. Blum, H., Beier, H. & Gross, H. J. (1987). Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 8, 93-99.
3. Cammue, B. P. A., De Bolle, M. F. C., Terras, F. R. G., Proost, P., Damme, J. V., Rees, S. B., Vanderleyden, J. & Broaekaert, W. F. (1992). Isolation and characterization of a novel class of plant antimicrobial peptide from Mirabilis jalapa L. seeds. J Biol Chem 267, 2228-2233.
4. Chen, K. Y., Ko, S. C., Hsueh, P. R., Luh, K. T. & Yang, P. C. (2001). Pulmonary fungal infection: emphasis on microbiological spectra, patient outcome, and prognostic factors. Chest 120, 177-184.
5. Dabur, R., Ali, M., Singh, H., Gupta, J. & Sharma, G. L. (2004). A novel antifungal pyrrole derivative from Datura metel leaves. Pharmazie 59, 568-570.
6. Dabur, R., Chhillar, A. K., Yadav, V., Kamal, P. K., Gupta, J. & Sharma, G. L. (2005). In vitro antifungal activity of 2-(3,4-dimethyl-2,5-dihydro-1H-pyrrol-2-yl)-1-methylethyl pentanoate, a dihydropyrrole derivative. J Med Microbiol 54, 549-552.
7. Dahot, U. A. (1998). Antimicrobial activity of small protein of Moringa oleifera leaves. J Islamic Acad Sci 11, 1-5.
8. Dahot, M. U. (1999). Antibacterial and antifungal activity of small protein of Indigofera oblongifolia leaves. J Ethnopharmacol 64, 277-282.
9. Demain, A. L. (1999). Pharmaceutically active secondary metabolites of microorganisms. Appl Microbiol Biotechnol 52, 455-463.
10. Galgoczy, L., Papp, T., Leiter, E., Marx, F., Pocsi, I. & Vagvolgyi, C. (2005). Sensitivity of different zygomycetes to the Penicillium chrysogenum antifungal protein (PAF). J Basic Microbiol 45, 136-141.
11. Gao, W. D., Cao, H. T., Ji, R. H. & Zhang, Z. C. (1994). Isolation and characterization of protein-biosynthesis inhibiting proteins from seeds of luffa cylindrica. Acta Biochim Biophys 26, 289-295.
12. Gupta, A. K. & Tomas, E. (2003). New antifungal agents. Dermatol Clin 21, 565-576.
13. Herbrecht, R. (2004). Voriconazole: therapeutic review of a new azole antifungal. Expert Rev Anti Infect Ther 2, 485-497.
14. Hong, S. Y., Oh, J. E., Kwon, M. Y., Choi, M. J., Lee, J. H., Lee, B. L., Moon, H. M. & Lee, K. H. (1998). Identification and characterization of novel antimicrobial decapeptides generated by combinatorial chemistry. Antimicrob Agents Chemother 42, 2534-2541.
15. Iijima, R., Kurata, S. & Natori, S. (1993). Purification, characterization, and cDNA cloning of an antifungal protein from hemolymph of Sarcophaga peregrina (flesh fly) larvae. J Biol Chem 268, 12055-12061.
16. Johnson, M. D., MacDougall, C., Ostrosky-Zeichner, L., Perfect, J. R. & Rex, J. H. (2004). Combination antifungal therapy. Antimicrob Agents Chemother 48, 693-715.
17. Laemmli, U. K. & Favre, M. (1973). Maturation of the head of bacteriophage T4. DNA packaging events. J Mol Biol 80, 575-599.
18. Latoud, C., Peypoux, F., Michel, G., Genet, R. & Morgat, J. (1986). Interactions of antibiotics of the iturin group with human erythrocytes. Biochim Biophys Acta 856, 526-535.
19. Lavermicocca, P., Valerio, F., Evidente, A., Lazzaroni, S., Corsetti, A. & Gobbetti, M. (2000). Purification and characterization of novel antifungal compounds from the sourdough Lactobacillus plantarum strain 21B. Appl Environ Microbiol 66, 4084-4090.
20. Lehrer, R. I., Lichtenstein, A. K. & Ganz, T. (1993). Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol 11, 105-128.
21. Leiter, E., Szappanos, H., Oberparleiter, C., Kaiserer, L., Csernoch, L., Pusztahelyi, T., Emri, T., Pocsi, I., Salvenmoser, W. & Marx, F. (2005). Antifungal protein PAF severely affects the integrity of the plasma membrane of Aspergillus nidulans and induces an apoptosis-like phenotype. Antimicrob Agents Chemother 49, 2445-2453.
22. Lodinová-Zádníková, R., Cukrowska, B. & Tlaskalova-Hogenova, H. (2003). Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years). Int Arch Allergy Immunol 131, 209-211.
23. Matricardi, P. M., Bjorksten, B., Bonini, S., Bousquet, J., Djukenovic, R., Dreborg, S., Gereda, J., Malling, H. J., Popov, T. & other authors (2003). Microbial products in allergy prevention and therapy. Allergy 58, 461-471.
24. Oude Lashof, A. M. & Kullberg, B. J. (2004). Amphotericin B: the end of an era. Ned Tijdschr Geneeskd 148, 1665-1668.
25. Rajesh & Sharma, G. L. (2002). Studies on antimycotic properties of Datura metel. J Ethnopharmacol 80, 193-197.
26. Rapp, R. P. (2004). Changing strategies for the management of invasive fungal infections. Pharmacotherapy 24, 4S-28S.
27. Richardson, M. D. (2005). Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother 56, i5-i11.
28. Richardson, M. D. & Warnock, D. W. (2003). Fungal Infection: Diagnosis and Management, 3rd edn. Oxford: Blackwell Publishing.
29. Roessner, C. A. & Scott, A. I. (1996). Genetically engineered synthesis of natural products: from alkaloids to corrins. Annu Rev Microbiol 50, 467-490.
30. Ruchel, R., Perske, C., Glass, B. & Basecke, J. (2006). A case of pulmonary aspergillosis with lack of response to caspofungin. Rev Iberoam Micol 23, 94-96.
31. Schelenz, S. & Ross, C. N. (2006). Limitations of caspofungin in the treatment of obstructive pyonephrosis due to Candida glabrata infection. BMC Infect Dis 6, 126.
32. Sims-McCallum, R. P. (2003). Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient. Am J Health Syst Pharm 60, 2352-2356.
33. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J. & Klenk, D. C. (1985). Measurement of protein using bicinchoninic acid. Anal Biochem 150, 76-85.
34. Sorensen, K. N., Kim, K. H. & Takemoto, J. Y. (1996). In vitro antifungal and fungicidal activities and erythrocytes toxicities of Pseudomonas syringae pv. syringae. Antimicrob Agents Chemother 40, 2710-2713.
35. Thompson, J. D., Higgins, D. G. & Gibson, T. J. (1994). CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position specific gap penalties and weight matrix choice. Nucleic Acids Res 22, 4673-4680.
36. Wegner, B., Baer, P., Gauer, S., Oremek, G., Hauser, I. A. & Geiger, H. (2005). Caspofungin is less nephrotoxic than amphotericin B in vitro and predominantly damages distal renal tubular cells. Nephrol Dial Transplant 20, 2071-2079.
37. Woo, J. H., Kitamura, E., Myuoga, H. & Yuto, K. (2002). An antifungal protein from the marine bacterium Streptomyces sp. strain AP77 is specific for Pythium porphyrae, a causative agent of red rot disease in Porphyra spp. Appl Environ Microbiol 68, 2666-2675.
38. Yadav, V., Mandhan, R., Dabur, R., Chhillar, A. K., Gupta, J. & Sharma, G. L. (2005). An antifungal fraction from Escherichia coli. J Med Microbiol 54, 375-379.
39. Zaas, A. K. & Alexander, B. D. (2005). Echinocandins: role in antifungal therapy. Expert Opin Pharmacother 6, 1657-1668.